Evidence map›Paper›PMID 29776368›Full record

ArticleHarm reduction journal2018

Comparing risk environments for HIV among people who inject drugs from three cities in Northern Mexico.

Angelica Ospina-Escobar, Carlos Magis-Rodríguez, Fatima Juárez, Dan Werb, Sergio Bautista Arredondo, Rubén Carreón, María Elena Ramos, Steffanie Strathdee

Abstract readComparative Study
In one paragraph

Article in Harm reduction journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. HIV and Substance Use in Latin America: A Scoping Review.International journal of environmental research and public health · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Angelica Ospina-EscobarEl Colegio de Mexico, Mexico City, Mexico.
Carlos Magis-RodríguezCentro Nacional para la Prevención y Control del SIDA (CENSIDA), Mexico City, Mexico.
Fatima JuárezEl Colegio de Mexico, Mexico City, Mexico.
Dan WerbDivision of Global Public Health, University of California, San Diego, USA. dwerb@ucsd.edu.ORCID 0000-0003-0614-9386
Sergio Bautista ArredondoInstituto Nacional de Salud Pública, Cuernavaca, Mexico.
Rubén CarreónInstituto Nacional de Salud Pública, Cuernavaca, Mexico.
María Elena RamosPrograma Compañeros AC, Ciudad Juarez, Mexico.
Steffanie StrathdeeDivision of Global Public Health, University of California, San Diego, USA.

Funding

Impact of Drug Policy Reform on the HIV Risk Environment among IDUs in TijuanaR37DA019829 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2010 to 2019
$6.7M
Evolving HIV/STI risk environments of FSWs on the Mexico/U.S. BorderR01DA028692 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROUWER, KIMBERLY C · 2010 to 2014
$3.2M
Epidemiology of HIV and Hepatitis C Among Injecting Drug Users in TijuanaR01DA019829 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2005 to 2009
$2.9M
Preventing HIV by modifying the context for injecting initiationDP2DA040256 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WERB, DANIEL M · 2015 to 2015
$2.3M
Modeling the Complex Dynamics between Behaviors and Environments Shaping HIV/STIsK01DA034523 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GAINES, TOMMI LYNN · 2012 to 2016
$905k
CIHR New Investigator AwardGlobal Fund to Fight AIDS, Tuberculosis and Malaria IMEX-901-G01-HHIV Trust Scholarship Award HIVRT15-100NIDA NIH HHS DP2 DA040256NIDA NIH HHS DP2 DA040256-01NIDA NIH HHS K01 DA034523NIDA NIH HHS R01 DA019829NIDA NIH HHS R01 DA028692NIDA NIH HHS R37 DA019829
6 · The paper itself

Abstract

backgroundA large body of research has investigated the rise of injection drug use and HIV transmission in Tijuana and Ciudad Juarez (CJ). However, little is known about the dynamics of injecting in Hermosillo. This study compares drug-related behaviors and risk environment for HIV of people who inject drugs (PWID) across Tijuana, CJ, and Hermosillo to identify factors that could explain differences in HIV prevalence.

methodsData from Tijuana belong to a prospective study (El Cuete IV). Data from Hermosillo and Ciudad Juarez belong to a cross-sectional study. Both studies collected data in places where PWID spend time. All participants completed quantitative behavioral and serological testing for HIV. Datasets were merged using only comparable variables. Descriptive statistics tests were used to compare sociodemographic and behavioral characteristics of people who inject drugs PWID sampled in each city. A logistic regression model was built to identify factors independently associated with the likelihood of reporting receptive syringe sharing in the past 6 months.

resultsA total of 1494 PWID provided data between March 2011 and May 2012. HIV prevalence differed significantly between participants in Tijuana (4.2%), CJ (7.7%), and Hermosillo (5.2%; p < 0.05). PWID from Hermosillo reported better living conditions, less frequency of drug injection, and lower prevalence of syringe sharing (p < 0.01). PWID from CJ reported a higher prevalence of syringe sharing and confiscation by police (p < 0.01). In a multivariable logistic regression model, living in Hermosillo compared to Tijuana (adjusted odds ratio [AOR] = 0.42, 95% confidence interval [CI] 0.29-0.61) and being female (AOR = 0.61, 95% CI 0.45-0.83) were protective against syringe sharing. Having used crystal meth (AOR = 1.62, 95% CI 1.24-2.13, p = 0.001), having experienced syringe confiscation by police in the last 6 months (AOR = 1.78, 95% CI 1.34-2.40), and lower perception of syringe availability (AOR = 2.15, 95% CI 1.59-2.91) were significantly associated with syringe sharing (p < 0.05).

conclusionsDifferences in HIV prevalence across cities reflect mainly differences in risk environments experienced by PWID, shaped by police practices, access to injection equipment, and dynamics of drug markets. Findings highlight the importance of ensuring sterile syringe availability through harm reduction services and a human rights approach to drug harms in northern Mexico and to generate better understanding of local dynamics and contexts of drug use for designing proper harm reduction programs.

Indexed as

AdultAge of OnsetCitiesCondomsFemaleHIV InfectionsHomosexuality, MaleHumansMaleMexicoNeedle SharingPrevalenceProspective StudiesRisk FactorsSexual PartnersSocioeconomic FactorsHIVNorthern MexicoPWIDRisk environment

Identifiers

PMID29776368
PMCPMC5960140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.